Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients

NCT00392327 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00392327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00392327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
May 23, 2007
Completion date
March 31, 2026
Enrollment
379 (actual)
Sites
185

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic medulloblastoma, medulloblastoma